Bausch Health Companies Inc. Payments for (Proceeds from) Other Investing Activities
Bausch Health Companies Inc. (BHC) reported Payments for (Proceeds from) Other Investing Activities of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-19.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2020-02-19
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for the quarter ending 2016-03-31 was $0.00.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for the quarter ending 2015-06-30 was $500.00K.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for the quarter ending 2015-03-31 was -$500.00K.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for the quarter ending 2014-06-30 was -$1.40M.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for fiscal 2019 was $0.00.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for fiscal 2017 was $25.00M.
- Bausch Health Companies Inc. payments for (proceeds from) other investing activities for fiscal 2016 was $0.00.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-19 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-19 | |||
| 2017-12-31 | $25.00M 10-K · filed 2020-02-19 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-20 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-06-07 | |||
| 2015-06-30 | $500.00K 10-Q · filed 2015-07-28 | $0.00 10-Q · filed 2015-07-28 | ||
| 2015-03-31 | -$500.00K 10-Q · filed 2016-06-07 | |||
| 2014-06-30 | -$1.40M 10-Q · filed 2015-07-28 | -$2.80M 10-Q · filed 2015-07-28 | ||
| 2014-03-31 | -$1.40M 10-Q · filed 2015-04-30 | |||
| 2010-12-31 | $1.70M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$553.00K derived: sum of 2 quarters · filed 2012-02-29 | -$910.00K derived: sum of 3 quarters · filed 2012-02-29 | -$923.00K 10-K · filed 2012-02-29 |
| 2009-09-30 | -$553.00K 10-Q · filed 2010-11-05 | -$910.00K derived: sum of 2 quarters · filed 2010-11-05 | -$923.00K 10-Q · filed 2010-11-05 | |
| 2009-06-30 | -$357.00K 10-Q · filed 2010-08-06 | -$370.00K 10-Q · filed 2010-08-06 | ||
| 2008-12-31 | $7.29M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |